ASH 2023: PERSEUS Trial Overview : vimarsana.com

Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.

Related Keywords

, Conference Perspectives , Multiple Myeloma , American Society Of Hematology , Cash , Newly Diagnosed Multiple Myeloma , Triplet Therapy , Quadruplet Therapy , Perseus Trial , Daratumumab , Bortezomib , Lenalidomide , Dexamethasone , Mvrd , Transplant Eligible , Fasct , Master Trial , Carfilzomib , Nmrd , Durable Response , Four Drug Combination ,